National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 389605

History of Changes from the VAERS Wayback Machine

First Appeared on 6/2/2010

VAERS ID: 389605
VAERS Form:
Age:0.3
Sex:Unknown
Location:Foreign
Vaccinated:0000-00-00
Onset:2010-03-01
Submitted:2010-05-28
Entered:2010-05-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Lymphadenitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0657046A

Write-up: This case was reported by a consumer and described the occurrence of invagination of intestine in a 3-month-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. In 2010, the subject received unspecified dose of ROTARIX (route unknown, batch number not provided). 2 days after vaccination with ROTARIX, the child was ok. In March 2010, 4 days after vaccination with ROTARIX, the subject experienced invagination of intestine and mesenteric lymphadenitis. The subject was hospitalised. At the time of reporting, the outcome of the events was unspecified. No further information is available because the subject changed his treating pediatrician.


Changed on 5/13/2013

VAERS ID: 389605 Before After
VAERS Form:
Age:0.3
Sex:Unknown
Location:Foreign
Vaccinated:0000-00-00
Onset:2010-03-01
Submitted:2010-05-28
Entered:2010-05-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - UN / UN
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Lymphadenitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0657046A

Write-up: This case was reported by a consumer and described the occurrence of invagination of intestine in a 3-month-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. In 2010, the subject received unspecified dose of ROTARIX (route unknown, batch number not provided). 2 days after vaccination with ROTARIX, the child was ok. In March 2010, 4 days after vaccination with ROTARIX, the subject experienced invagination of intestine and mesenteric lymphadenitis. The subject was hospitalised. At the time of reporting, the outcome of the events was unspecified. No further information is available because the subject changed his treating pediatrician.


Changed on 9/14/2017

VAERS ID: 389605 Before After
VAERS Form:(blank) 1
Age:0.3
Sex:Unknown
Location:Foreign
Vaccinated:0000-00-00
Onset:2010-03-01
Submitted:2010-05-28
Entered:2010-05-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Lymphadenitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0657046A

Write-up: This case was reported by a consumer and described the occurrence of invagination of intestine in a 3-month-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. In 2010, the subject received unspecified dose of ROTARIX (route unknown, batch number not provided). 2 days after vaccination with ROTARIX, the child was ok. In March 2010, 4 days after vaccination with ROTARIX, the subject experienced invagination of intestine and mesenteric lymphadenitis. The subject was hospitalised. At the time of reporting, the outcome of the events was unspecified. No further information is available because the subject changed his treating pediatrician.


Changed on 2/14/2018

VAERS ID: 389605 Before After
VAERS Form:1
Age:0.3
Sex:Unknown
Location:Foreign
Vaccinated:0000-00-00
Onset:2010-03-01
Submitted:2010-05-28
Entered:2010-05-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Lymphadenitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0657046A

Write-up: This case was reported by a consumer and described the occurrence of invagination of intestine in a 3-month-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. In 2010, the subject received unspecified dose of ROTARIX (route unknown, batch number not provided). 2 days after vaccination with ROTARIX, the child was ok. In March 2010, 4 days after vaccination with ROTARIX, the subject experienced invagination of intestine and mesenteric lymphadenitis. The subject was hospitalised. At the time of reporting, the outcome of the events was unspecified. No further information is available because the subject changed his treating pediatrician.


Changed on 6/14/2018

VAERS ID: 389605 Before After
VAERS Form:1
Age:0.3
Sex:Unknown
Location:Foreign
Vaccinated:0000-00-00
Onset:2010-03-01
Submitted:2010-05-28
Entered:2010-05-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Lymphadenitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0657046A

Write-up: This case was reported by a consumer and described the occurrence of invagination of intestine in a 3-month-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. In 2010, the subject received unspecified dose of ROTARIX (route unknown, batch number not provided). 2 days after vaccination with ROTARIX, the child was ok. In March 2010, 4 days after vaccination with ROTARIX, the subject experienced invagination of intestine and mesenteric lymphadenitis. The subject was hospitalised. At the time of reporting, the outcome of the events was unspecified. No further information is available because the subject changed his treating pediatrician.


Changed on 8/14/2018

VAERS ID: 389605 Before After
VAERS Form:1
Age:0.3
Sex:Unknown
Location:Foreign
Vaccinated:0000-00-00
Onset:2010-03-01
Submitted:2010-05-28
Entered:2010-05-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Lymphadenitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0657046A

Write-up: This case was reported by a consumer and described the occurrence of invagination of intestine in a 3-month-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. In 2010, the subject received unspecified dose of ROTARIX (route unknown, batch number not provided). 2 days after vaccination with ROTARIX, the child was ok. In March 2010, 4 days after vaccination with ROTARIX, the subject experienced invagination of intestine and mesenteric lymphadenitis. The subject was hospitalised. At the time of reporting, the outcome of the events was unspecified. No further information is available because the subject changed his treating pediatrician.


Changed on 9/14/2018

VAERS ID: 389605 Before After
VAERS Form:1
Age:0.3
Sex:Unknown
Location:Foreign
Vaccinated:0000-00-00
Onset:2010-03-01
Submitted:2010-05-28
Entered:2010-05-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Lymphadenitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0657046A

Write-up: This case was reported by a consumer and described the occurrence of invagination of intestine in a 3-month-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. In 2010, the subject received unspecified dose of ROTARIX (route unknown, batch number not provided). 2 days after vaccination with ROTARIX, the child was ok. In March 2010, 4 days after vaccination with ROTARIX, the subject experienced invagination of intestine and mesenteric lymphadenitis. The subject was hospitalised. At the time of reporting, the outcome of the events was unspecified. No further information is available because the subject changed his treating pediatrician.


Changed on 10/14/2018

VAERS ID: 389605 Before After
VAERS Form:1
Age:0.3
Sex:Unknown
Location:Foreign
Vaccinated:0000-00-00
Onset:2010-03-01
Submitted:2010-05-28
Entered:2010-05-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Intussusception, Lymphadenitis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0657046A

Write-up: This case was reported by a consumer and described the occurrence of invagination of intestine in a 3-month-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. In 2010, the subject received unspecified dose of ROTARIX (route unknown, batch number not provided). 2 days after vaccination with ROTARIX, the child was ok. In March 2010, 4 days after vaccination with ROTARIX, the subject experienced invagination of intestine and mesenteric lymphadenitis. The subject was hospitalised. At the time of reporting, the outcome of the events was unspecified. No further information is available because the subject changed his treating pediatrician.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=389605&WAYBACKHISTORY=ON


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166